BIOLOGICAL: Blinatumomab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
BIOLOGICAL: UCART22
BIOLOGICAL: CLLS52
DIAGNOSTIC_TEST: NGS-MRD
DRUG: Myeloablative allogeneic HCT with a non-TBI conditioning regimen
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
DRUG: AVM0703
BIOLOGICAL: CD19/CD22 CAR T-Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Calaspargase Pegol
DRUG: Cytarabine
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
DRUG: Hydrocortisone Sodium Succinate
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Prednisolone
DRUG: Prednisone
DRUG: Revumenib
DRUG: Vincristine Sulfate
BIOLOGICAL: Inotuzumab Ozogamicin
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Cyclophosphamide
RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Fludarabine
DRUG: Melphalan
BIOLOGICAL: CAR-20/19-T cells (5 x 10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (1 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells
BIOLOGICAL: Anti-CD19/CD20/CD22 CAR T-Cells
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Busulfan
DRUG: Busulfan
DRUG: Fludarabine
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
DRUG: Melphalan
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
PROCEDURE: Bone Marrow Hematopoietic Stem Cell Transplantation
DRUG: Post-transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient-Reported Outcomes
DRUG: Blinatumomab
DRUG: Asciminib
BIOLOGICAL: NKX019
BIOLOGICAL: 19-28z/IL-18 CAR T cells
BIOLOGICAL: Blinatumomab
DRUG: Ibrutinib
DRUG: Calaspargase pegol (S95015)
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
DRUG: Asparaginase Erwinia chrysanthemi
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Calaspargase Pegol
DRUG: Cyclophosphamide
DRUG: Cytarabine
PROCEDURE: Diagnostic Imaging
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Vincristine
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
BIOLOGICAL: Cetuximab
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: Dexamethasone
DRUG: Mitoxantrone
DRUG: PEG asparaginase
DRUG: Bortezomib
DRUG: Vorinostat
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Blinatumomab
DRUG: Ziftomenib
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
GENETIC: KUR-502
DRUG: CM4620
DRUG: Venetoclax
DRUG: Dexamethasone
DRUG: Inotuzumab Ozogamicin
BIOLOGICAL: Fully human anti CD19 CAR-T Cell Dose
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: iC9-CAR19 cells
DRUG: Rimiducid
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Decitabine
DRUG: Dexamethasone
DRUG: Palbociclib
DRUG: Sorafenib
DRUG: Conditioning Chemotherapy
BIOLOGICAL: Cord blood graft
DRUG: MRX-2843
GENETIC: CD7.CAR/28zeta CAR T cells
DEVICE: Alpha/Beta T-cell and B-cell depleted HCT
DRUG: Blinatumomab
DRUG: Busulfan
DRUG: Fludarabine
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
DRUG: Post-Transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient Reported Outcomes
DRUG: Melphalan
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Scan
DRUG: Calaspargase Pegol
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Magnetic Resonance Imaging
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
RADIATION: Radiation Therapy
DRUG: Thioguanine
DRUG: Vincristine Sulfate
BIOLOGICAL: CD19/CD22-CAR-transduced T cells
DRUG: cyclophosphamide
DRUG: fludarabine
DRUG: Anti-thymocyte globulin (rabbit)
DRUG: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: G-CSF
DRUG: Melphalan
DRUG: Mesna
DRUG: Rituximab
DRUG: Tacrolimus
DRUG: Thiotepa
BIOLOGICAL: HPC,A Infusion
DEVICE: CliniMACS
DRUG: Sirolimus
DRUG: SAR443579
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Busulfan
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Haploidentical Hematopoietic Cell Transplantation
BIOLOGICAL: Lapine T-Lymphocyte Immune Globulin
PROCEDURE: Lumbar Puncture
PROCEDURE: Matched Unrelated Donor Hematopoietic Cell Transplantation
DRUG: Melphalan
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
PROCEDURE: Myeloablative Conditioning
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
PROCEDURE: T-Cell Depletion Therapy
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: TURALIO(R)
DRUG: revumenib
DRUG: cobicistat
DRUG: Daratumumab
PROCEDURE: Haploidentical Bone Marrow/Kidney
BIOLOGICAL: Murine CART19
GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells
BIOLOGICAL: Dilanubicel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Electrocardiography
PROCEDURE: Computed Tomography
DRUG: ABL001
DRUG: Dasatinib
DRUG: Prednisone
DRUG: Blinatumomab
DRUG: Blinatumomab
DRUG: Low-intensity chemotherapy regimen
DRUG: SOC chemotherapy regimen
DRUG: Tagraxofusp
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Azacitidine
DRUG: Methotrexate
DRUG: Cytarabine IT
DRUG: Hydrocortisone
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
BIOLOGICAL: Azer-cel
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Bendamustine
DRUG: Blinatumomab
DRUG: Inotuzumab Ozogamicin
DRUG: Hyper-CVAD
DRUG: Mini-hyper-CVD
DRUG: Venetoclax
DRUG: Standard Chemotherapy
PROCEDURE: TCRαβ+/CD19+ depleted Haploidentical HSCT
DRUG: Zoledronate
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Fludarabine Phosphate
BIOLOGICAL: Granulocyte Colony-Stimulating Factor
PROCEDURE: Hematopoietic Cell Transplantation
PROCEDURE: Intensity-Modulated Radiation Therapy
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Leucovorin
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexrazoxane
DRUG: Calaspargase Pegol
DRUG: Erwinia asparaginase
DEVICE: CliniMACS
BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Busulfan
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
BIOLOGICAL: Rituximab
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Ponatinib
DRUG: Venetoclax
DRUG: Mini-hyper CVD
DRUG: Ruxolitinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Vincristine
DRUG: Pegaspargase
DRUG: Rituximab
DRUG: Methotrexate (Intrathecal Administration)
DRUG: Methotrexate (Intravenous Administration)
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Thioguanine
DRUG: Methotrexate Oral Product
BIOLOGICAL: BEAM-201
DRUG: Blinatumomab
DRUG: Dasatinib
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Venetoclax
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Lumbar Puncture
PROCEDURE: Biospecimen Collection
BIOLOGICAL: CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
DRUG: AKR1C3-activated Prodrug OBI-3424
BIOLOGICAL: ADCT-602
BIOLOGICAL: Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
BIOLOGICAL: Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
DRUG: VIP943
DRUG: Inotuzumab ozogamicin
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Cytarabine
DRUG: Diphenhydramine
DRUG: Acetaminophen
DRUG: Methylprednisolone
DRUG: DSP-5336
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
DRUG: Cyclophosphamide
DRUG: Cyclosporine
PROCEDURE: Diagnostic Imaging
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
OTHER: Survey Administration
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
BIOLOGICAL: OrcaGraft (Orca-Q)
BIOLOGICAL: Blinatumomab
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Bortezomib
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Etoposide
BIOLOGICAL: Ofatumumab
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate Liposome
BIOLOGICAL: BAFFR-CAR T cells
DRUG: Siltuximab
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
BIOLOGICAL: Ofatumumab
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Fludarabine
DRUG: Busulfan
DRUG: Melphalan
DRUG: Rituximab
DRUG: Levetiracetam
DRUG: KT-253
DRUG: Tecartus
BIOLOGICAL: AUTO1
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Blinatumomab
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Prednisone
DRUG: Pegfilgrastim
DRUG: Inotuzumab ozogamicin
DRUG: Rituximab
DRUG: Dexamethasone
DRUG: AZD0486
DRUG: Dasatinib
BIOLOGICAL: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
GENETIC: Autologous CD5.CAR/28zeta CAR T cells
GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells
DEVICE: Miltenyi CliniMACS Prodigy ® system
DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
DRUG: Meropenem
DRUG: Micafungin
DRUG: Akt/ERK Inhibitor ONC201
DRUG: Fludarabine
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
RADIATION: Total Marrow Irradiation
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Mercaptopurine
DRUG: Doxorubicin
DRUG: 1A46 Injection
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Basiliximab
DRUG: Fludarabine Phosphate
DRUG: Indium In 111-DOTA-Basiliximab
DRUG: Melphalan
BIOLOGICAL: Palifermin
RADIATION: Total Lymphoid Irradiation
RADIATION: Total Marrow Irradiation
BIOLOGICAL: Yttrium Y 90 Basiliximab
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
DRUG: BMF-500
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Bendamustine
BIOLOGICAL: Filgrastim-sndz
DRUG: Fludarabine
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
BIOLOGICAL: Rituximab
DRUG: Tacrolimus
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: CD70-CAR T cell infusion (Autologous)
DRUG: Mesna
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Echocardiography
PROCEDURE: Electrocardiography
PROCEDURE: Lumbar Puncture
DRUG: Mesna
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Ponatinib Hydrochloride
DRUG: Prednisone
DRUG: Vincristine Sulfate
DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
BIOLOGICAL: huCART19-IL18
DRUG: Blinatumomab
DEVICE: Current Wearable Heatlth Monitoring System (CWHMS)
BIOLOGICAL: PIT565
OTHER: Ossium HPC Marrow, Bone Marrow Transplant
OTHER: Pre-transplant conditioning - Myeloablative (MAC)
OTHER: Pre-transplant conditioning - Reduced Intensity (RIC)
OTHER: Post-transplant treatment
DRUG: EAGD T-cell infusion (Phase I)
DRUG: EAGD T-cell infusion (Expansion)
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Tacrolimus
BIOLOGICAL: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs
DRUG: Methotrexate
DRUG: Cyclophosphamide
BIOLOGICAL: Peripheral Blood Stem Cell
DRUG: Cyclosporine
DRUG: Sirolimus
DRUG: Busulfan
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Biospecimen Collection
DRUG: Inotuzumab Ozogamicin
BIOLOGICAL: CD19-CAR(Mem) T-cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
DEVICE: CliniMACS
PROCEDURE: Leukapheresis
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
OTHER: Questionnaire Administration
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
DRUG: CD22CART infusion
DRUG: Tisagenlecleucel
DRUG: Fludarabine Phosphate
DRUG: Melphalan
RADIATION: Intensity-Modulated Radiation Therapy
RADIATION: Total Marrow Irradiation
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Peripheral Blood Stem Cell Transplantation
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Laboratory Biomarker Analysis
DRUG: Bleximenib
DRUG: etoposide
DRUG: cyclophosphamide
RADIATION: total marrow irradiation
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Dual-Energy Computed Tomography
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
DRUG: Melphalan
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total Marrow and Lymphoid Irradiation
OTHER: Laboratory Biomarker Analysis
DRUG: Venetoclax
DRUG: Vincristine Liposomal
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Pheresis
DRUG: Placebo Administration
DRUG: Stem Cell Mobilization Therapy
DRUG: Azacitidine
DRUG: Venetoclax
DRUG: LP-118
BIOLOGICAL: Blinatumomab
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Ponatinib
DRUG: Inotuzumab ozogamicin
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Ponatinib
DRUG: Methotrexate for Injection
PROCEDURE: Allogenic Stem Cell Transplantation
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Azacitidine
DRUG: Venetoclax
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Nelarabine
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
DRUG: Calaspargase Pegol
DRUG: Rituximab
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Duvelisib
DRUG: Ascentage Pharma HQP1351 bioavailable inhibitor
DRUG: Blinatumomab
DRUG: SLS009
DRUG: venetoclax
DRUG: azacitidine
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: BMF-219
DRUG: Vactosertib
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Natural Killer Cells
DRUG: Blinatumomab
DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
DRUG: Treg CD34+HSPC (Orca-T)
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: CD19 Directed CAR T Cell
DRUG: Autologous Anti-CD19 CAR-expressing T Lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
OTHER: Questionnaire Administration
DRUG: Palbociclib
DRUG: Dexamethasone
DRUG: Bortezomib
DRUG: Doxorubicin
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Anaplastic Large Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.